Ampio Pharmaceuticals (NYSE:AMPE) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note issued on Tuesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE opened at $0.00 on Tuesday. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $7.47. The stock has a market capitalization of $2,497.00, a P/E ratio of 0.00 and a beta of 3.67.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.